Compugen to Present at the 2006 C.E. Unterberg Towbin Emerging Growth Opportunities Conference
10 Julio 2006 - 6:00AM
Business Wire
Compugen Ltd. (NASDAQ: CGEN) announced today that Martin Gerstel,
Chairman of the Board, is scheduled to present at the 2006 C.E.
Unterberg, Towbin Emerging Growth Opportunities Conference at 3:36
PM (Eastern Time) on Wednesday, July 12, 2006 at the Mandarin
Oriental Hotel in New York City. A live Webcast of the presentation
will be available on the Compugen Website at
http://www.wsw.com/webcast/ceut4/cgen/ and a reply will be
available for 90 days following the presentation. About Compugen:
Compugen is a biotech company focused on drug and biomarker
discovery. The Company's powerful discovery engines enable the
predictive discovery of numerous potential therapeutics and
diagnostic biomarkers. This capability results from the Company's
decade-long pioneering efforts in the deeper understanding of
important biological phenomena at the molecular level through the
incorporation of ideas and methods from mathematics, computer
science and physics into traditional biology, chemistry and
medicine. To date, Compugen's discovery efforts have focused mainly
on cancer, cardiovascular and immune-related diseases. Product
development is pursued both in-house and through collaborative
arrangements. The Company's primary commercialization pathway is
the out-licensing of validated therapeutic and diagnostic product
candidates to leading companies under co-development and/or
milestone and revenue sharing agreements. Compugen has established
an agricultural biotechnology affiliate - Evogene, and a
small-molecule drug discovery affiliate - Keddem Bioscience. For
additional information, please visit Compugen's corporate Website
at www.cgen.com.
Compugen (NASDAQ:CGEN)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Compugen (NASDAQ:CGEN)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024